Clinical study
Avis-PHAGEinLYON Clinic
| Status | Recruiting |
|---|---|
| Type | Observational study |
| Countries | France |
| Conditions studied | Bone Infection |
| Study years | 2023–2029 (estimated) |
| Entry review | 2026-10-03 |
Participation
Check the study record or contact the study team for current recruitment and eligibility.
Study eligibility
Inclusion Criteria: * \- Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/2028. * Avis-PHAGEinLYON clinic study information notice provided to the patient Exclusion Criteria: * \- Opposition of trial participant
Study description
Avis-PHAGEinLYON Clinic study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients referred to the Hospices Civils de Lyon for a medical advice for a phage therapy from 2015 to 2028. The primary objective is to quantify the phage therapy requests received at the Hospices Civils de Lyon. 1500 patients will be included in the study.
Study registrations
| ClinicalTrials.gov | NCT05883995 |
|---|
Recorded study locations (1)
Locations listed in the study record; this does not confirm current recruitment or treatment outside the study. A site label may be older than the overall study status.
Centre de Référence des Infections Ostéo-Articulaires complexes (CRIOAc) - Hôpital de la Croix-Rousse
Lyon, France
Recorded site status: Recruiting. Study location source ↗
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Study ID | nct05883995 |
|---|